antitrust
-
News
Anticancer drugs, EU Antitrust investigation into Aspen
The European Commission wants to see clearly the prices of anti-cancer drugs practiced by the pharmaceutical company Aspen. An investigation is open…
Leggi » -
News
The uniform prices set in Germany for prescription medicines are contrary to EU law
A German association for the fight against unfair competition believes that the uniform selling prices imposed by pharmacies…
Leggi » -
News
Antitrust: 5 million fine to the pharmaceutical company Aspen
The Antitrust Authority has sanctioned the pharmaceutical company Aspen with a fine of over 5 million euros. Aspen bought…
Leggi » -
News
Missing drugs. Federconsumatori: Aifa, Government and Ministry of Health responsible for failure to give aid
Until now, AIFA has proved to be an almost useless body on this matter. It's time to put an end to the lobby of…
Leggi » -
News
The liberalizations of Guidi. "Shock" rules for pharmacies. And class C drugs with prescription for free sale
There are two hypotheses under study. The first provides for the possibility for Parapharmacies to also sell drugs of…
Leggi » -
News
Tumours, drugs and the increase in 1500%
The Competition and Market Authority will verify the hypothesis of abuse of the company's dominant position in the drug market…
Leggi » -
News
EU Antitrust: fine of 427.7 million to Servier and 5 producers for cartel
To Servier 331 million for having prevented the marketing of a generic. To the other 5 generic producers 97 million:…
Leggi » -
News
Medicines. Roche, we pay the Antitrust fine. But we trust in the Tar ruling
The company emphasizes that “payment does not imply acknowledgment of any liability by Roche, which confirms full…
Leggi » -
Main news
Antitrust proposes to the Government and Parliament: “No ceiling on the number of pharmacies. In healthcare, separate control and provision of services”
These two of the proposals contained in the report that the Competition and Market Authority sent to the Government and…
Leggi » -
Main news
Antitrust: "Healthcare-pharmaceutical sector the most problematic". Report to Parliament
Because these are "areas in which competitive distortions directly affect the well-being of the community" and "fundamental rights ...
Leggi »